Revascularization could improve areas traditionally considered necrotic

Original title: Prevalence of Regional Myocardial Thinning and Relationship With Myocardial Scarring in Patients With Coronary Artery Disease. Reference: Dipan J. Shah et al. JAMA. 2013;309(9):909-918

Regional left ventricular (LV) wall thinning is believed to represent chronic myocardial infarction. In fact, the most recent guidelines, both European and American, have concluded that “Images that show regional myocardial thinning in absence of contraction with no other cause than the ischemic, are diagnosed as chronic infarction”. Regional left ventricular (LV) wall thinning is believed to represent chronic myocardial infarction. However, recent case reports using delayed-enhancement cardiovascular magnetic resonance (CMR) imaging raise the possibility that thinning may occur with little or no scarring. 

The recent incorporation of Delayed Enhancement MR imaging to the study of patients with ischemic heart disease could change the previous paradigm. This prospective study included 1055 patients with a history of ischemic heart disease between 2000 and 2008, where diagnosed through 1.5T DE-MR in 1.5T. A ≤ 5.5 mm thinning was considered at the end of diastole. Scarring tissue was also analyzed (hyperintense areas) within thinning. Of 1055 patients analyzed, 201 (19%) had regional wall thinning of some LV area.

Among patients with thinning undergoing revascularization and follow-up CMR (RR=0.72, p<0.001), there was improvement in the systolic global function (RR=0.53, p<0.001) and a reduction in end-diastole volume (RR=0.42, p=0.007). It was also observed that the Q waves disappeared from the ECG. The latter was inversely correlated to scar extent within the thinned region.

Conclusion: 

Among patients with CAD referred for CMR and found to have regional wall thinning, limited scar burden was present in 18% and was associated with improved contractility and resolution of wall thinning after revascularization.

Editorial Comment: 

This study has a major limitation, the decision to revascularize was left to the attending physicians, which could affect selection. These results contradict the present guidelines and paradigmes and require further randomized studies for confirmation. 

SOLACI.ORG

More articles by this author

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...